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In July 2016, the first autochthonous case of tick-borne 
encephalitis was diagnosed in the Netherlands, five 
days after a report that tick-borne encephalitis virus 
(TBEV) had been found in Dutch ticks. A person in their 
60s without recent travel history suffered from neuro-
logical symptoms after a tick bite. TBEV serology was 
positive and the tick was positive in TBEV qRT-PCR. 
TBEV infection should be considered in patients with 
compatible symptoms in the Netherlands.
Until recently, tick-borne encephalitis virus (TBEV) 
was thought to be absent in the Netherlands and all 
cases of tick-borne encephalitis (TBE) were considered 
imported from endemic regions [1,2]. On 30 June 2016, 
the Dutch National Institute for Public Health and the 
Environment (RIVM) reported that Dutch Ixodes ricinus 
ticks were RT-PCR positive for TBEV-Eu, but no autoch-
thonous cases had been diagnosed at that point [3]. 
This is the first report of an autochthonous case of TBE 
in the Netherlands.
Case description
In June 2016, a person in their 60s presented at a hos-
pital in the middle of the Netherlands with complaints 
of malaise, fatigue, headache, nausea and a subfebrile 
temperature (37.9 °C) after a tick bite. The malaise and 
fatigue had started earlier that month (day 0), the other 
symptoms started two days later. On day 4, the general 
practitioner discovered a tick on the patient’s left leg, 
removed it and started antibiotic treatment with doxy-
cycline for 10 days. In retrospect, the bite is most likely 
to have occurred two days before onset of symptoms in 
a forested area between Driebergen en Maarn. Initially, 
the patient improved after antibiotic treatment and the 
symptoms disappeared. However, on day 12 the patient 
suffered from tremors, slow speech, weakness and 
fatigue. Subsequently, these symptoms progressed 
and fever (40.0 °C), nausea and vomiting developed 
on day 21. The patient was referred to the hospital on 
day 24. Neurological and general physical examination 
revealed no other abnormalities, especially no signs of 
meningism. Laboratory blood tests showed no specific 
abnormalities (Table 1), nor did a computed tomogra-
phy scan of the brain. Serum and cerebrospinal fluid 
(CSF) tested negative for Lyme borreliosis (Table 2), 
however, CSF showed a mononuclear cell reaction 
(Table 1).
Additional diagnostic tests were conducted to exclude 
other infectious diseases (Table 2). Although TBE was 
not considered endemic in the Netherlands, it was 
added to the differential diagnosis after the RIVM 
reported that TBEV had been detected in ticks in the 
eastern part of the country (Sallandse Heuvelrug), 
100 km from Driebergen [3]. In 2016, the patient had 
not travelled to the Sallandse Heuvelrug or any other 
regions known to be endemic for TBE. Their last stay 
abroad had been in October 2015, in Paderborn, 
Germany, which is not a region endemic for TBEV [4]. 
They had not visited other places abroad in the past 
five years. The patient was not vaccinated against 
TBEV, but had received a vaccination against yellow 
fever virus in 2005.
Serum taken on day 24 and 36 was positive for anti-
TBEV IgM (452 and 162 Vienna units (VIEU)/mL, respec-
tively; cut-off: 63 VIEU/mL) and IgG (> 650 and > 650 
VIEU/mL, respectively; cut-off: 100 VIEU/mL) (Progen 
Biotechnik). CSF was negative for IgM but IgG-positive. 
In addition, both sera were positive in a TBEV neutrali-
sation assay (1/640). A TBEV-specific qRT-PCR on CSF, 
blood and urine was negative. 
Fortunately, the patient had saved the dead tick, 
which was was positive for TBEV by qRT-PCR with a Ct 
value of 21. Interestingly, based on comparison of par-
tial NS5 sequences of the PCR products, TBEV in the 
patient’s tick showed 93% homology with those found 
in Sallandse Heuvelrug, but 99% homology with a pro-
totype TBEV-Eu Neudörfl strain.
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During clinical observation, the patient gradually 
improved. At discharge on day 37, no focal neurological 
deficits were present, but fatigue and mild subjective 
cognitive complaints (Montreal Cognitive Assessment 
26/30) remained.
Discussion
This is the first report of a case of TBE in a patient 
infected in the Netherlands. Although liquor was nega-
tive for anti-TBEV IgM antibodies, the high serum IgM 
and IgG levels in an unvaccinated patient, combined 
with a typical biphasic clinical presentation and TBEV 
detected in the tick collected from the patient, con-
firmed the diagnosis of TBE [5]. Since the patient had 
not travelled abroad in the previous seven months, 
they must have been infected in the Netherlands, as 
the incubation period for TBE is no longer than a month 
and Ixodes species only feed for several days per host 
[1,6].
TBE is considered an emerging disease due to its rising 
incidence and the expansion in new, previously unin-
fected, areas but until now, autochthonous human TBEV 
infection had not been reported in the Netherlands 
[3,7]. The presence of TBEV in ticks collected in the 
Netherlands was recently confirmed [3]. Interestingly, 
preliminary sequence data suggest that the TBEV 
detected in the tick from our patient had a higher 
homology to the prototype TBEV-Eu strain Neudörfl 
than to those found in the Sallandse Heuvelrug. 
The Neudörlf strain and related TBEV strains have 
been found throughout Europe, including Germany. 
Although it is highly likely that the TBEV-infected tick 
that bit our patient was acquired between Driebergen 
and Maarn, the exact origin of the tick requires further 
Table 1
Clinical, chemical and haematological tests on blood and cerebrospinal fluid at hospital admission, tick-borne encephalitis 
case, the Netherlands, July 2016*
Patient Reference value
Blood 
Haemoglobin (mmol/L) 7.6 8.5–11.0
Leukocyte count (109/L) 6.9 4.0–10.0
Thrombocyte count (109/L) 211 150–400
Erythrocyte sedimentation rate (mm/hour) 60 0–19
Sodium (mmol/L) 131 135–145
Potassium (mmol/L) 3.9 3.6–5.1
Glucose (mmol/L) 6.1 4.0–7.0
C-reactive protein (mg/L) 12 0–10
Cerebrospinal fluid 
Polynuclear cells (cells/µL) 2 Not applicable 
Mononuclear cells (cells /µL) 61 Not applicable
Erythrocytes (cells /µL) 128 Not applicable
Glucose (mmol/L) 3.5 2.0–4.0
Protein (g/L) 0.89 0.15–0.45
Table 2
Performed tests for infectious diseases, tick-borne encephalitis case, the Netherlands, July 2016*
Blood Cerebrospinal fluid
Bartonella henselae IgM negative ND 
Borrelia burgdorferi C6 IgG negative IgG negative  IgM negative
PCR negative  
serum/liquor index IgM and IgG negative
Treponema pallidum Serological screening negative ND
Tuberculosis IGRA negative ND
HIV Serological screening negative ND
Enterovirus ND PCR negative
Parechovirus ND PCR negative
Herpes simplex virus 1 and 2 ND PCR negative
Varicella zoster virus ND PCR negative
HIV: human immunodificiency virus; IGRA: interferon gamma release assay; ND: Not done; PCR: polymerase chain reaction.
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investigation. Further studies are needed to determine 
the geographic spread and genetic diversity of TBEV in 
ticks in the Netherlands.
This case is an excellent example of the importance of 
tenacity and persistence in difficult diagnostic cases. 
Looking beyond guidelines and current evidence can 
lead to new findings, which can be beneficial not only 
for the individual patient but also for public health. 
Surveillance and widespread messages by public 
health institutes can be of great value to the diagnostic 
process, as they can provide clinicians with clues for 
the diagnosis of disease in individual patients. 
This case has important implications. On a patient 
level, clinicians in the Netherlands need to add TBE to 
the differential diagnosis for patients hospitalised with 
(meningo)encephalitis or meningitis who may have 
been exposed to tick bites. On a public health level, 
further studies are needed to determine the extent of 
TBEV infections in humans in the Netherlands. These 
studies include surveillance of TBEV in humans, ani-
mals and ticks, as well as determining the risk of 
acquiring TBEV infection by serosurveillance studies 
in the general population, patient populations with 
unknown neurological disease and for professions at 
high risk for tick bites.
*Erratum
This article was originally published with an incorrectly or-
dered reference list. This was corrected on 19 August 2016. 
We apologise for this mistake.
On request of the authors, the date in the Table titles was 
corrected from June 2016 to July 2016. This change was made 
on 19 August 2016.
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